Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 27

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 3
Chunk 27
---
 party reimbursement policies; and  
 ──────────────────────────────────────────────────────

  developments concerning current or future strategic alliances or acquisitions.  

In addition, volatility and
low market price of our ADSs may adversely impact investors’ interest in our securities. A decline in investors’ interest
may prompt further volatility and decrease in market price.

If we are or become a passive foreign investment
company (“ PFIC”), then that would subject our U. S. shareholders to adverse tax rules.

Holders of our ADSs who are
U. S. taxpayers will be subject to particular income tax rules if we are a passive foreign investment company, or PFIC. These rules could
result in a reduction in the after-tax return to a “ U. S. Holder” of our ADSs and reduce the value of our ADSs. For U. S. federal
income tax purposes, we will be classified as a PFIC for any taxable year in which (i) 75% or more of our gross income is passive
income, or (ii) at least 50% of the average value of all of our assets for the taxable year produce or are held for the production
of passive income. For this purpose, cash is considered to be an asset that produces passive income.

If we are classified as a
PFIC in any year that a U. S. Holder owns ADSs, the U. S. Holder will generally continue to be treated as holding ADSs of a PFIC in all
subsequent years, notwithstanding that we are not classified as a PFIC in a subsequent year. Dividends received by the U. S. Holder and
gains realized from the sale of our ADSs would be taxed as ordinary income and subject to an interest charge. We urge U. S. investors to
consult their own tax advisors about the application of the PFIC rules and certain elections that may help to minimize adverse U. S. federal
income tax consequences in their particular circumstances. For further information, see Item 10. E - Additional Information - 
Taxation - U. S. Taxation.

The requirements of being a public company may strain our resources
and divert management’s attention.

Upon listing on the Nasdaq
Capital Market, we became subject to the reporting requirements of the U. S. Securities Exchange Act of 1934 (the “ Exchange
Act”), the Sarbanes-Oxley Act, the listing requirements of the Nasdaq Capital Market and other applicable securities rules and regulations